Accès ouvert
2026
article
OpenAlex
Sharon L. Mulvagh, S. E. Inzucchi, Nikolaus Marx, Neil R Poulter et autres
Importance: Individuals with type 2 diabetes (T2D) are at high risk of atherosclerotic cardiovascular disease (ASCVD). In the SOUL randomized clinical trial, once-daily oral semaglutide reduced risk of major adverse cardiovascular (CV) events by 14% vs placebo in people with T2D and …
ca, us, de, gb, dk, in, ar, bg, tr, ua, th, es, cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Rodica Pop-Busui, S. Munkgaard Rasmussen, John E. Deanfield, John B. Buse et autres
Importance: Heart failure (HF) is a common complication of type 2 diabetes (T2D). Oral semaglutide reduced the risk of major adverse cardiovascular (CV) events (MACE; comprising CV death, nonfatal myocardial infarction, or nonfatal stroke) in people with T2D in the SOUL trial, …
us, dk, gb, de, ca, cz, sg, bg
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Maja Gradinjan Centner, Daniela Kenjerić, Ema Schönberger, Hrvoje Centner et autres
Type 1 diabetes has become prevalent among the adult population, who have increasingly gained access to sensing technology. This study delved into the impact of diet, nutritional status, and the use of a continuous glucose monitoring system (CGM) on glycemic regulation among …
hr
(code pays fourni par la source)